News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
86,596 Results
Type
Article (10780)
Company Profile (6)
Press Release (75810)
Multimedia
Podcasts (62)
Webinars (3)
Section
Business (22520)
Career Advice (568)
Deals (4139)
Drug Delivery (39)
Drug Development (14533)
Employer Resources (45)
FDA (2824)
Job Trends (2615)
News (43406)
Policy (4201)
Tag
Academia (587)
Accelerated approval (5)
Adcomms (5)
Allergies (22)
Alliances (4329)
ALS (61)
Alzheimer's disease (716)
Antibody-drug conjugate (ADC) (28)
Approvals (2807)
Artificial intelligence (55)
Autoimmune disease (12)
Automation (2)
Bankruptcy (46)
Best Places to Work (1955)
BIOSECURE Act (8)
Biosimilars (27)
Biotechnology (4)
Bladder cancer (10)
Brain cancer (8)
Breast cancer (54)
Cancer (475)
Cardiovascular disease (50)
Career advice (489)
Career pathing (10)
CAR-T (52)
CDC (11)
Cell therapy (129)
Cervical cancer (2)
Clinical research (11951)
Collaboration (144)
Compensation (35)
Complete response letters (5)
COVID-19 (595)
CRISPR (15)
C-suite (32)
Cystic fibrosis (15)
Data (714)
Denatured (2)
Depression (22)
Diabetes (109)
Diagnostics (707)
Digital health (5)
Diversity (2)
Diversity, equity & inclusion (11)
Drug discovery (31)
Drug pricing (52)
Drug shortages (7)
Duchenne muscular dystrophy (62)
Earnings (12995)
Editorial (28)
Employer branding (3)
Employer resources (37)
Events (11590)
Executive appointments (84)
FDA (3195)
Fibrodysplasia Ossificans Progressiva (1)
Frontotemporal dementia (4)
Funding (131)
Gene editing (24)
Generative AI (4)
Gene therapy (103)
GLP-1 (283)
Government (866)
Grass and pollen (2)
Guidances (63)
Healthcare (2548)
HIV (8)
Huntington's disease (23)
IgA nephropathy (18)
Immunology and inflammation (40)
Immuno-oncology (4)
Indications (7)
Infectious disease (628)
Inflammatory bowel disease (12)
Inflation Reduction Act (3)
Influenza (9)
Intellectual property (19)
Interviews (119)
IPO (1997)
IRA (21)
Job creations (735)
Job search strategy (405)
Kidney cancer (4)
Labor market (20)
Layoffs (229)
Leadership (5)
Legal (737)
Liver cancer (11)
Longevity (4)
Lung cancer (64)
Lymphoma (75)
Machine learning (3)
Management (16)
Manufacturing (68)
MASH (35)
Medical device (1781)
Medtech (1782)
Mergers & acquisitions (2239)
Metabolic disorders (285)
Multiple sclerosis (42)
NASH (11)
Neurodegenerative disease (81)
Neuropsychiatric disorders (9)
Neuroscience (1015)
NextGen: Class of 2025 (859)
Non-profit (783)
Now hiring (6)
Obesity (149)
Opinion (111)
Ovarian cancer (12)
Pain (28)
Pancreatic cancer (18)
Parkinson's disease (90)
Partnered (4)
Patents (54)
Patient recruitment (22)
Peanut (15)
People (4410)
Pharmaceutical (2)
Pharmacy benefit managers (5)
Phase I (3138)
Phase II (5312)
Phase III (4638)
Pipeline (435)
Policy (79)
Postmarket research (519)
Preclinical (1100)
Press Release (4)
Prostate cancer (16)
Psychedelics (9)
Radiopharmaceuticals (25)
Rare diseases (110)
Real estate (472)
Recruiting (18)
Regulatory (3168)
Reports (15)
Research institute (435)
Resumes & cover letters (63)
Rett syndrome (4)
RNA editing (1)
RSV (15)
Schizophrenia (31)
Series A (22)
Series B (7)
Sickle cell disease (19)
Special edition (9)
Spinal muscular atrophy (27)
Sponsored (8)
Startups (400)
Stomach cancer (3)
Supply chain (13)
Tariffs (24)
The Weekly (58)
Vaccines (169)
Venture capital (23)
Weight loss (131)
Women's health (9)
Worklife (9)
Date
Today (5)
Last 7 days (112)
Last 30 days (319)
Last 365 days (5214)
2025 (3024)
2024 (5601)
2023 (5864)
2022 (7522)
2021 (7920)
2020 (7578)
2019 (6116)
2018 (4586)
2017 (4282)
2016 (4279)
2015 (4947)
2014 (3519)
2013 (2574)
2012 (2836)
2011 (2893)
2010 (2351)
Location
Africa (181)
Alabama (8)
Alaska (3)
Arizona (20)
Asia (4955)
Australia (1064)
California (1073)
Canada (237)
China (99)
Colorado (52)
Connecticut (40)
Delaware (48)
Europe (12768)
Florida (155)
Georgia (25)
Idaho (5)
Illinois (89)
India (6)
Indiana (71)
Japan (65)
Kansas (8)
Kentucky (1)
Louisiana (6)
Maine (38)
Maryland (141)
Massachusetts (874)
Michigan (63)
Minnesota (83)
Missouri (5)
Montana (1)
Nebraska (5)
Nevada (10)
New Hampshire (15)
New Jersey (431)
New Mexico (11)
New York (487)
North Carolina (145)
Northern California (521)
Ohio (31)
Oklahoma (2)
Oregon (7)
Pennsylvania (249)
Puerto Rico (2)
Rhode Island (10)
South America (222)
South Carolina (2)
Southern California (384)
Tennessee (18)
Texas (187)
United States (4480)
Utah (34)
Virginia (31)
Washington D.C. (24)
Washington State (105)
Wisconsin (5)
86,596 Results for "imidomics sl".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
SELLAS Meets All Primary Endpoints in Phase 2 Trial of SLS009 in r/r AML and Receives FDA Guidance to Advance into First-Line Therapy Study
July 16, 2025
·
10 min read
Press Releases
Tonix Pharmaceuticals Announces On-line Publication of Phase 3 RESILIENT Trial Results of TNX-102 SL for Fibromyalgia in the Peer Reviewed Journal, Pain Medicine
July 9, 2025
·
12 min read
Press Releases
SELLAS Presents Preclinical Efficacy of SLS009 in ASXL1 Mutated Colorectal Cancer at 2025 ASCO Annual Meeting
June 2, 2025
·
5 min read
Press Releases
Tonix Pharmaceuticals Presented Data and Analyses of TNX-102 SL Treatment Effects on Fibromyalgia at the Annual European Congress of Rheumatology (EULAR) 2025
June 16, 2025
·
14 min read
Press Releases
Tonix Pharmaceuticals Announces First Patient Dosed in Phase 2 OASIS Study of TNX-102 SL for Reduction of Acute Stress Reaction
May 21, 2025
·
12 min read
Press Releases
SELLAS Life Sciences Announces First Pediatric AML Patient Dosed in the Ongoing Phase 2 Trial of SLS009 r/r AML
May 16, 2025
·
4 min read
Press Releases
SELLAS Unveils Breakthrough Preclinical Data Highlighting Efficacy of SLS009 in TP53 Mutated AML at the 2025 AACR Conference
April 28, 2025
·
6 min read
Business
IMIDomics Establishes a License and Collaboration Partnership with the University of Barcelona to Advance Treatments for IMIDs
IMIDomics Inc. today announced a strategic license and collaboration agreement with the University of Barcelona (UB).
October 11, 2023
·
3 min read
Press Releases
SELLAS Announces Positive Overall Survival in Cohort 3 from the Ongoing Phase 2 Trial of SLS009 in r/r AML
April 8, 2025
·
6 min read
Deals
Agile Therapeutics Inc. Announces Definitive Merger Agreement with Insud Pharma, S.L.
Agile Therapeutics, Inc. today announced that it has entered into a definitive merger agreement (“Merger Agreement”) with Insud Pharma, S.L.
June 26, 2024
·
10 min read
1 of 8,660
Next
